Quantum Computing declines premarket after announcing a direct offering to raise $40 million. read more ​ ​Quantum Computing declines premarket after announcing a direct offering to raise $40 million. read moreÂ
Regeneron and Sanofi’s Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a decision expected by April 2025. read more ​ ​Regeneron and Sanofi’s Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a decision expected by April 2025. read moreÂ
US retail sales in October surpass expectations with a 0.4% increase, the highest since July 2024. This signals resilience in consumer spending before the presidential election. read more ​ ​US retail sales in October surpass expectations with a 0.4% increase, the highest since July 2024. This signals resilience in consumer spending before the presidential election.
Altria Group is “undervalued,” Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of $1.38. read more ​ ​Altria Group is “undervalued,” Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of $1.38. read moreÂ
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.
